Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.
about
Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical CharacteristicsScientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United StatesIllicit use of androgens and other hormones: recent advancesToxicant-associated steatohepatitisEnvironmental pollution: a tangible risk for NAFLD pathogenesisNonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.Hepatotoxicity of herbal and dietary supplements: an update.Association between soil heavy metals and fatty liver disease in men in Taiwan: a cross sectional studyReview article: herbal and dietary supplement hepatotoxicity.Mastabol induced acute cholestasis: A case report.Recreational Anabolic-Androgenic Steroid Use Associated With Liver Injuries Among Brazilian Young Men.Liver cirrhosis in selected autoimmune diseases: a nationwide cohort study in Taiwan.Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine.The influence of concomitant use of alcohol, tobacco, cocaine, and anabolic steroids on lipid profiles of Brazilian recreational bodybuilders.
P2860
Q26748911-86416A36-F117-4B48-A7AF-34A75A8ED924Q26767376-3A08B649-9CE0-44EA-901F-93FCDC8F61D0Q26824840-A460DDB4-2AD4-4CBA-933F-EADB2FE0A685Q27687049-6D57EDCB-69D7-4607-85E5-19D0E5712B83Q28661241-801EA7E6-AD31-44DD-B293-83F286EB96BDQ30234736-6C790BF3-BC1D-4928-B739-8B6C9F2B5972Q33904576-870273FC-EC4A-465D-8B62-F28FEF1A16B9Q34194760-2FA85A4B-9533-4F80-B2E2-E631AF7A2A84Q34462677-D39234E7-FFCD-4018-9943-DA02BB7F5999Q37612102-793FC463-12E6-4C1B-ADA7-87882B3FCB1DQ38057354-EFC1DA05-5F41-42A4-8220-1FA1F6427CF3Q39451314-E4239836-75BA-4004-9C22-761EDAA24E4CQ40917805-F239D8D5-E958-4B43-AA10-8F648EA39F25Q41312527-E878E440-8F3D-4CDB-BF09-E6BFAD1E02FDQ41970103-546D0500-21CC-4F03-9174-BCAD5C2F333DQ47879422-F7637C41-8111-4535-88FC-DCDE0AAC0EEF
P2860
Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@en
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@nl
type
label
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@en
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@nl
prefLabel
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@en
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@nl
P2093
P2860
P1433
P1476
Anabolic-androgenic steroids: ...... ssociated fatty liver disease.
@en
P2093
Antonio Ricardo Andrade
Bernardo Rios Salles
Bruno Nachef
Carlos Eduardo Almeida
Cláudio C Zoppi
Crimério Ribeiro dos Santos
Helma P Cotrim
P2860
P304
P356
10.1111/J.1478-3231.2010.02346.X
P577
2010-10-11T00:00:00Z